New Therapeutic Approaches in PAH
Spring 09

Near-Term Novel Therapies for PAH
by David Langleben, MD

Evaluating Recent Therapeutic Trials in PAH: Raising the bar in Clinical Investigation
by Murali Chakinala, MD

Update on the Development of Oral Prostacyclin Analogs for the Treatment of PAH
by R. James White, MD, PhD

Winter 08-09 Vol 7, No 4

The Role of Echocardiography in the Diagnosis and Assessment of Pulmonary Hypertension
by Stephen C. Mathai, MD, MHS asd Paul M. Hassoun, MD

Cardiopulmonary Hemodynamics in Pulmonary Hypertension: Pressure Tracings, Waveforms, and More
by Francisco J. Soto, MD, MS and James F. Kleczka, MD

Role of Cardiac MRI in Pulmonary Hypertension
by Ravi Desai, MD, Fernando Torres, MD and Himanshu Gupta, MD

Ambulatory Hemodynamic Monitoring in Pulmonary Arterial Hypertension
by Robert P. Frantz, MD, Barbro Kjellstrom, PhD and Michael McGoon, MD

Autumn 2008

The Metabolic Syndrome and Cardiac Function
by Heiko Bugger, MD, PhD and E. Dale Abel, MD, PhD

National Heart Lung and Blood Institute Hopkins Specialized Center in Clinical Oriented Research (SCCOR): Molecular Determinants of Pulmonary Arterial Hypertension
by Paul M. Hassoun, MD

Specialized Center in Clinical Oriented Research (SCCOR) Update: Mechanisms and Treatment of Lung Vascular Disease in Infants and Children
by Kurt Stenmark, MD

Getting More From Right Heart Catheterization: A Focus on the Right Ventricle
by Hunter C. Champion, MD, PhD

Animal Models of Human Severe PAH
by Ivan F. McMurtry, PhD

Summer 2008

Pulmonary Hypertension in Systemic Lupus Erythematosus
by Kristin B. Highland, MD, MSCR and Gary Gilkeson, MD

Pulmonary Hypertension and the Antiphospholipid Syndrome
by Raj S. Kasthuri, MD and Robert A. S. Roubey, MD

Scleroderma Associated Pulmonary Hypertension
by Victoria K. Shanmugam, MD and Virginia D. Steen, MD